Analysis of Cost and Treatment Effects in the Care Given for Graves' Disease: A Swedish Cost–Utility Analysis
Tx was more cost-effective than RAI when ablative treatment is advocated. Prediction score for recurrence directing patients to earlier Tx is cost-effective and enables the introduction of a specialist thyroid nurse. Health economic evaluations should accompany future guidelines.
Authors
- Mirna Abraham‐Nordling (ORCID: https://orcid.org/0000-0002-6538-7301)
- Lars Lindholm (ORCID: https://orcid.org/0000-0002-1633-2179)
- Gabriel Sjölin (ORCID: https://orcid.org/0000-0003-2367-8503)
- Göran Wallin (ORCID: https://orcid.org/0000-0002-5359-1102)
- Annika Jonsson
Institutions
- Örebro University (SE)
- Sahlgrenska University Hospital (SE)
- Karolinska Institutet (SE)
- Knowledge Foundation (SE)
- Örebro University Hospital (SE)
- University of Gothenburg (SE)
- Umeå University (SE)
Publication Details
- Journal
- Endocrinology Diabetes & Metabolism
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1002/edm2.70034
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Lunds Universitet
- Skånes universitetssjukhus